Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study on Multidimensional Prevention of Sintilimab Induced irAEs Based on GEP Pattern Recognition

NCT04840355 is registered in ClinicalTrials.gov with Guohui Li as lead sponsor.

NCT NCT04840355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04840355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study on Multidimensional Prevention of Sintilimab Induced irAEs Based on GEP Pattern Recognition
Lead sponsor
Guohui Li
Phase
Observational
Overall status
Recruiting
Start date
February 26, 2021
Completion date
November 14, 2025
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune related adverse events, pd-1